Your prediction
Adamis Pharmaceuticals Corp. Stock
Our community identified positive and negative aspects for Adamis Pharmaceuticals Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adamis Pharmaceuticals Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adamis Pharmaceuticals Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adamis Pharmaceuticals Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -4.650% | 17.138% | 35.152% | -54.422% | 40.946% | -43.580% | -92.777% |
| Pacira Pharmaceuticals | -0.570% | 4.217% | -19.907% | -20.642% | -19.907% | -49.415% | -69.107% |
| Twist Bioscience Corp | -1.130% | 2.316% | 24.582% | -30.524% | 28.474% | 39.357% | -73.299% |
Comments
Adamis Pharmaceuticals Co. (NASDAQ: ADMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADMP provided by MarketBeat
